Suppr超能文献

miRNA-154-5p 的上调可预防骨肉瘤的发生。

Upregulation of miRNA-154-5p prevents the tumorigenesis of osteosarcoma.

机构信息

Department of Orthopaedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China.

Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, China.

出版信息

Biomed Pharmacother. 2020 Apr;124:109884. doi: 10.1016/j.biopha.2020.109884. Epub 2020 Jan 27.

Abstract

BACKGROUND

Osteosarcoma (OS) is a primary malignant bone sarcoma in human worldwide. It has been shown that the level of microRNA-154-5p (miR-154-5p) was downregulated in human OS tissues. However, the mechanisms by which miR-154-5p regulates the proliferation, apoptosis and invasion in OS remain unclear. Thus, the present study aimed to investigate the role of miR-154-5p during the tumorigenesis of OS.

METHODS

The level of miR-154-5p in human OS tissues was detected by RT-qPCR. In addition, the effects of miR-154-5p on apoptosis and invasion of OS cells were assessed by flow cytometry and transwell assays, respectively. Meanwhile, the dual luciferase reporter system assay was performed to explore the interaction of miR-154-5p and E2F5.

RESULTS

The level of miR-154-5p was downregulated in OS tissues. Overexpression of miR-154-5p significantly inhibited the proliferation, migration and invasion of MG63 cells. In addition, upregulation of miR-154-5p obviously induced apoptosis in MG63 cells via upregulation of Bax and cleaved caspase 3, and downregulation of Bcl-2. Moreover, luciferase reporter assay identified that E2F5 was the binding target of miR-154-5p. Meanwhile, overexpression of miR-154-5p induced cell cycle arrest in MG63 cells via inhibiting the expressions of E2F5, Cyclin E1 and CDK2. Furthermore, in vivo assays indicated that overexpression of miR-154-5p notably inhibited the tumor growth in an OS xenograft model.

CONCLUSION

These results indicated that miR-154-5p may function as a potential tumor suppressor in OS. Therefore, miR-154-5p might be a novel therapeutic option for the treatment of OS.

摘要

背景

骨肉瘤(OS)是一种在全球范围内发生于人类的原发性恶性骨肉瘤。已有研究表明,miR-154-5p 在人骨肉瘤组织中呈下调表达。然而,miR-154-5p 调控骨肉瘤增殖、凋亡和侵袭的机制尚不清楚。因此,本研究旨在探讨 miR-154-5p 在骨肉瘤发生发展过程中的作用。

方法

采用 RT-qPCR 检测人骨肉瘤组织中 miR-154-5p 的水平。此外,通过流式细胞术和 Transwell 实验分别评估 miR-154-5p 对骨肉瘤细胞凋亡和侵袭的影响。同时,采用双荧光素酶报告基因系统实验探究 miR-154-5p 与 E2F5 的相互作用。

结果

miR-154-5p 在骨肉瘤组织中呈下调表达。过表达 miR-154-5p 可显著抑制 MG63 细胞的增殖、迁移和侵袭。此外,上调 miR-154-5p 通过上调 Bax 和 cleaved caspase 3,下调 Bcl-2,明显诱导 MG63 细胞凋亡。而且,荧光素酶报告基因实验鉴定出 E2F5 是 miR-154-5p 的结合靶标。同时,过表达 miR-154-5p 通过抑制 E2F5、Cyclin E1 和 CDK2 的表达,诱导 MG63 细胞周期停滞。此外,体内实验表明,过表达 miR-154-5p 可显著抑制骨肉瘤异种移植模型中的肿瘤生长。

结论

这些结果表明,miR-154-5p 可能在骨肉瘤中发挥潜在的肿瘤抑制作用。因此,miR-154-5p 可能成为骨肉瘤治疗的一种新的治疗选择。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验